Paladin launches Silenor in Canada
Silenor, which is not a controlled substance, will be made available in 3mg or 6mg oral tablets. Paladin interim president and chief executive officer Mark Beaudet said, "Canadians
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
The AB-rated phenoxybenzamine hydrochloride capsule is the authorized generic of Dibenzyline. Prasco chief executive officer Chris Arington said, "Patients and customers alike benefit from WellSpring’s commitment to maintaining
Metronidazole 1.3% vaginal gel antibiotic development product is a topical antibiotic developed for the treatment of bacterial vaginosis. The agreement includes upfront and certain milestone payments in addition
Around 130 patients will be randomized with either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy in the investigator-sponsored, placebo-controlled trial. The primary endpoint is overall